Correction to: Trends in Use of Sulfonylurea Types Among US Adults with Diabetes: NHANES 1999–2020 (Journal of General Internal Medicine, (2023), 38, 8, (2009-2010), 10.1007/s11606-023-08067-w)

Research output: Contribution to journalComment/debatepeer-review

Abstract

Figure 1 in the published paper did not reproduce correctly, the revised figure is below: (Figure presented.) Trends in sulfonylurea use among US adults with diagnosed diabetes, NHANES 1999 to 2020. Shaded areas indicate 95% confidence intervals. First-generation sulfonylurea includes chlorpropamide and tolazamide.

Original languageEnglish (US)
JournalJournal of general internal medicine
DOIs
StateAccepted/In press - 2023

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint

Dive into the research topics of 'Correction to: Trends in Use of Sulfonylurea Types Among US Adults with Diabetes: NHANES 1999–2020 (Journal of General Internal Medicine, (2023), 38, 8, (2009-2010), 10.1007/s11606-023-08067-w)'. Together they form a unique fingerprint.

Cite this